52 related articles for article (PubMed ID: 8567412)
1. Glutathione protection against gentamicin ototoxicity depends on nutritional status.
Lautermann J; McLaren J; Schacht J
Hear Res; 1995 Jun; 86(1-2):15-24. PubMed ID: 8567412
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.
Blunston MA; Yonovitz A; Woodahl EL; Smolensky MH
Chronobiol Int; 2015; 32(9):1223-32. PubMed ID: 26506922
[TBL] [Abstract][Full Text] [Related]
3. Protective Effects of Acupuncture Against Gentamicin-Induced Ototoxicity in Rats: Possible Role of Neurotrophin-3.
Zhou P; Ma W; Sheng Y; Duan M; Zhang X
Med Sci Monit; 2017 Jan; 23():446-451. PubMed ID: 28121979
[TBL] [Abstract][Full Text] [Related]
4. Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration.
Tan J; Wang Y; Yip X; Glynn F; Shepherd RK; Caruso F
Adv Mater; 2012 Jul; 24(25):3362-6. PubMed ID: 22610659
[TBL] [Abstract][Full Text] [Related]
5. Effects of Cross-linked Hyaluronic Acid in a Rat Model of Vestibular and Cochlear Toxicity.
Erkoç E; Çakır Çetin A; Mungan Durankaya S; Çilaker Mıçılı S; Keskinoğlu P; Yılmaz O; Kırkım G; Güneri EA
Turk Arch Otorhinolaryngol; 2023 Sep; 61(3):124-133. PubMed ID: 38020411
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients.
Rivetti S; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895824
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Ototoxicity and Otoprotection.
Steyger PS
Otolaryngol Clin North Am; 2021 Dec; 54(6):1101-1115. PubMed ID: 34774227
[TBL] [Abstract][Full Text] [Related]
8. Mild Therapeutic Hypothermia and Putative Mechanisms of Hair Cell Survival in the Cochlea.
Spankovich C; Walters BJ
Antioxid Redox Signal; 2021 Dec; 36(16-18):1203-14. PubMed ID: 34619988
[No Abstract] [Full Text] [Related]
9. Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity.
Steyger PS
Am J Audiol; 2021 Oct; 30(3S):887-900. PubMed ID: 34415784
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms Involved in Ototoxicity.
Steyger PS
Semin Hear; 2011 Aug; 32(3):217-228. PubMed ID: 34234387
[TBL] [Abstract][Full Text] [Related]
11. Use of the guinea pig in studies on the development and prevention of acquired sensorineural hearing loss, with an emphasis on noise.
Naert G; Pasdelou MP; Le Prell CG
J Acoust Soc Am; 2019 Nov; 146(5):3743. PubMed ID: 31795705
[TBL] [Abstract][Full Text] [Related]
12. Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.
Ruhl D; Du TT; Wagner EL; Choi JH; Li S; Reed R; Kim K; Freeman M; Hashisaki G; Lukens JR; Shin JB
J Neurosci; 2019 Apr; 39(15):2951-2964. PubMed ID: 30733218
[TBL] [Abstract][Full Text] [Related]
13. Drug-Induced Ototoxicity: Diagnosis and Monitoring.
Campbell KCM; Le Prell CG
Drug Saf; 2018 May; 41(5):451-464. PubMed ID: 29404977
[TBL] [Abstract][Full Text] [Related]
14. Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity.
Nicholas BD; Francis S; Wagner EL; Zhang S; Shin JB
Front Cell Neurosci; 2017; 11():303. PubMed ID: 29033791
[TBL] [Abstract][Full Text] [Related]
15. Monitoring neonates for ototoxicity.
Garinis AC; Kemph A; Tharpe AM; Weitkamp JH; McEvoy C; Steyger PS
Int J Audiol; 2018 Sep; 57(sup4):S41-S48. PubMed ID: 28949262
[TBL] [Abstract][Full Text] [Related]
16. Cellular glutathione content in the organ of Corti and its role during ototoxicity.
Majumder P; Duchen MR; Gale JE
Front Cell Neurosci; 2015; 9():143. PubMed ID: 25972783
[TBL] [Abstract][Full Text] [Related]
17. Survival of auditory hair cells.
Seymour ML; Pereira FA
Cell Tissue Res; 2015 Jul; 361(1):59-63. PubMed ID: 25743696
[TBL] [Abstract][Full Text] [Related]
18. Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.
Le Prell CG; Ojano-Dirain C; Rudnick EW; Nelson MA; DeRemer SJ; Prieskorn DM; Miller JM
J Assoc Res Otolaryngol; 2014 Jun; 15(3):375-93. PubMed ID: 24590390
[TBL] [Abstract][Full Text] [Related]
19. Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases.
Shulman E; Belakhov V; Wei G; Kendall A; Meyron-Holtz EG; Ben-Shachar D; Schacht J; Baasov T
J Biol Chem; 2014 Jan; 289(4):2318-30. PubMed ID: 24302717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
